L-Clausenamide alleviates LPS-induced ALI by inhibiting caspase-3 cleavage activity and normalizing intracellular ATP level, cellular and mitochondrial membrane potential, and mitochondrial morphology. The gene discussed is CASP3; the disease is acute respiratory distress syndrome.